Thanks for the post! I think genetic engineering for increasing IQ can indeed be super valuable, and is quite neglected in society. However, I would be very surprised if it was among the areas where additional investment generates the most welfare per $:
Open Philanthropy (OP) estimated that funding R&D (research and development) is 45 % as cost-effective as giving cash to people with 500 $/year.
People in extreme poverty have around 500 $/year, and unconditional cash transfer to them are like 1⁄3 as cost-effective as GiveWell’s (GW’s) top charities. GW used to consider such transfers around 10 % as cost-effective as their top charities, but now thinks they are 3 to 4 times as cost-effective as previously.
So I think R&D is like 15 % (= 0.45/3) as cost-effective as GW’s top charities.
I estimate the Shrimp Welfare Project (SWP) is 64.3 k times as cost-effective as GW’s top charities.
So I believe SWP is like 429 k (= 64.3*10^3/0.15) times as cost-effective as R&D (neglecting the beneficial or harmful effects of R&D on animals; it is unclear to me whether saving human lives is beneficial or harmful).
Trusting these numbers, genetic engineering would have to be 429 k times as cost-effective as typical R&D for it to be as cost-effective as SWP. I can see it being 10 times as cost-effective as R&D, but this is not anything close to enough to make it competitive with SWP.
Thanks for the great summary, Kave!
Nitpick. SWP received 1.82 M 2023-$ (= 1.47*10^6*1.24) during the year ended on 31 March 2024, which is 1.72*10^-8 (= 1.82*10^6/(106*10^12)) of the gross world product (GWP) in 2023, and OP estimated R&D has a benefit-to-cost ratio of 45. So I estimate SWP can only be up to 1.29 M (= 1/(1.72*10^-8)/45) times as cost-effective as R&D due to this increasing SWP’s funding.
Fair points, although I do not see how they would be sufficiently strong to overcome the large baseline difference between SWP and general R&D. I do not think reducing the nearterm risk of human extinction is astronomically cost-effective, and I am sceptical of longterm effects.